Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights Pipeline Progress NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline vTv Therapeutics Q1 2026 Earnings Massive EPS Surprise on OneTime Gains Shares Slip NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline GNLN Q2 2023 Earnings Massive EPS Miss Amid Operational Challenges ASUR Q1 2026 Earnings EPS Surpasses Estimates by 183 Recurring Revenue Growth Drives Profitability